Home / Business and Economy / Judge Limits Ketamine Questions in Musk vs. OpenAI Trial
Judge Limits Ketamine Questions in Musk vs. OpenAI Trial
14 Mar
Summary
- Judge Rogers set trial boundaries, excluding Musk's ketamine use.
- Musk seeks up to $134 billion in damages from OpenAI and Microsoft.
- Trial date is set for April 28, featuring prominent AI figures.
The upcoming trial between Elon Musk and OpenAI, along with Microsoft, will largely exclude discussions of Musk's alleged ketamine use. US District Judge Yvonne Gonzalez Rogers ruled on Friday in Oakland, California, that such questioning is irrelevant unless more evidence of its effects during key times is presented.
The trial, scheduled to commence on April 28, will delve into OpenAI's founding a decade ago and Musk's subsequent departure. Musk is pursuing damages totaling up to $134 billion from the generative AI company and Microsoft, alleging they defrauded him by deviating from their nonprofit mission. OpenAI and Microsoft have denied these claims.
Judge Rogers also indicated that the jury's damages findings would be advisory, with her making the final decision. She expressed doubt about the methodology used by Musk's expert witness, who estimated damages between $79 billion and $134 billion, calling the report "not particularly persuasive."
Key figures expected to testify include Sam Altman, Greg Brockman, Ilya Sutskever, and OpenAI's former chief technology officer Ermira Murati, as well as Microsoft CEO Satya Nadella. The judge emphasized that these prominent witnesses would not receive special treatment and must use public entrances.
